Legislators
Bills
Statements
Lobbying
Travel
- Bills
- S.4333
S.4333: CLEAR Act
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced May 26, 2022
- Latest Major Action May 26, 2022
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in Senate - May 26, 2022
Bill Summary
Consistent Legal Evaluation And Regulation of Medical Products Act or the CLEAR Act This bill requires the Food and Drug Administration to regulate contrast agents for medical imaging devices, radioactive drugs, over-the-counter monograph drugs, and ophthalmic drug articles (i.e., eye droppers) as drugs rather than medical devices.
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
May 26, 2022 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
May 26, 2022 |
Introduced in the Senate by Tina Smith (D-Minn.) |